Select Medical (SEM) Stock Price, News & Analysis

Company Overview

Select Medical Holdings Corporation is a leading provider of post-acute care services in the United States. The company operates a network of long-term acute care hospitals, inpatient rehabilitation hospitals and outpatient rehabilitation clinics. Through strategic joint ventures with health systems and hospital partners, Select Medical delivers specialized care for patients recovering from serious injuries, post-surgical complications or severe illnesses.

In its long-term acute care hospitals, Select Medical offers extended respiratory therapy, wound care and complex medical management for patients requiring intensive support beyond a traditional acute care setting. Its inpatient rehabilitation hospitals focus on restoring functional independence through physical therapy, occupational therapy, speech therapy and neurorehabilitation services. The company’s outpatient clinics provide follow-up services for patients transitioning back to their homes, including physical and occupational therapy, pain management and sports medicine treatments.

Founded in 1996, Select Medical completed its initial public offering in 2007, grew quickly through acquisitions and joint ventures, and returned to the public markets in 2018 after a period of private ownership. Over the years, the company has expanded its footprint by partnering with leading health systems to develop new hospitals and clinics. This approach has enabled Select Medical to invest in specialized staff training, advanced clinical protocols and facility enhancements that support patient outcomes and care quality.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical serves patients across more than 30 states, operating hundreds of facilities that cater to diverse communities. The company is led by a senior executive team with deep experience in healthcare operations and post-acute care delivery. By focusing on integrated care pathways and collaborative partnerships, Select Medical aims to improve long-term patient recovery while addressing the growing demand for specialized rehabilitation and acute care services.

Key Stats

• Today's Range: $14.44 to $14.84
• 50-Day Range: $14.38 to $15.49
• 52-Week Range: $14.03 to $40.98
• Volume: 905,485 shs
• Average Volume: 990,645 shs
• Market Capitalization: $1.89 billion
• P/E Ratio: 10.99
• Dividend Yield: 1.70%
• Price Target: $26.00
• Consensus Rating: Moderate Buy

Select Medical Stock Analysis - MarketRank™

Select Medical scored higher than 100% of companies evaluated by MarketBeat, and ranked 1st out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Select Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Select Medical has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 5.0 / 5
• Proj. Earnings Growth: 20.51%

Earnings Growth

Earnings for Select Medical are expected to grow by 20.51% in the coming year, from $1.17 to $1.41 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Select Medical is 10.99, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.84.

Price to Earnings Ratio vs. Sector

The P/E ratio of Select Medical is 10.99, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.13.

Price to Earnings Growth Ratio

Select Medical has a PEG Ratio of 0.78. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Select Medical has a P/B Ratio of 0.96. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.76% of the float of Select Medical has been sold short.

Short Interest Ratio / Days to Cover

Select Medical has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Select Medical has recently decreased by 9.01%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Select Medical pays a meaningful dividend of 1.71%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Select Medical does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Select Medical is 18.66%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Select Medical will have a dividend payout ratio of 17.73% next year. This indicates that Select Medical will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 4.8 / 5
• Environmental Score: -0.92

Percentage of Shares Shorted

2.76% of the float of Select Medical has been sold short.

Short Interest Ratio / Days to Cover

Select Medical has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Select Medical has recently decreased by 9.01%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: 0.83

News Sentiment

Select Medical has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Select Medical this week, compared to 5 articles on an average week.

MarketBeat Follows

Only 1 people have added Select Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 4.2 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Select Medical insiders have sold 1,184.00% more of their company's stock than they have bought. Specifically, they have bought $315,420.00 in company stock and sold $4,050,000.00 in company stock.

Percentage Held by Insiders

11.60% of the stock of Select Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

89.48% of the stock of Select Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SEM Stock Analysis - Frequently Asked Questions

How have SEM shares performed this year?

Select Medical's stock was trading at $18.85 at the start of the year. Since then, SEM shares have decreased by 21.9% and is now trading at $14.72.

How were Select Medical's earnings last quarter?

Select Medical Holdings Corporation (NYSE:SEM) announced its earnings results on Thursday, May, 1st. The health services provider reported $0.44 EPS for the quarter, missing analysts' consensus estimates of $0.45 by $0.01. Select Medical's quarterly revenue was down 24.4% on a year-over-year basis.
Read the conference call transcript.

Is Select Medical doing a stock buyback?

Select Medical's board initiated a stock buyback plan on Thursday, May 1st 2025, which allows the company to buy back $1,000,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 42.6% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's board believes its shares are undervalued.

Does Select Medical have any subsidiaries?

The following companies are subsidiaries of Select Medical: AbsoluteCVO, ACC Capital, Actra Rehabilitation Associates, Advantage Rehabilitation Clinics, Alexandria Sports, Allevant Solutions, Ambulatory Care Solutions, and more.

Who are Select Medical's major shareholders?

Select Medical's top institutional investors include Wedge Capital Management L L P NC (0.13%), CX Institutional (0.07%) and Wealth Enhancement Advisory Services LLC (0.01%). Insiders that own company stock include Robert A Ortenzio, David S Chernow, Parvinderjit S Khanuja, Robert G Breighner Jr and Marilyn B Tavenner.
View institutional ownership trends.

How do I buy shares of Select Medical?

Shares of SEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Select Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Select Medical investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST).

Company Calendar

• Last Earnings: 5/01/2025
• Record date for 5/29 Dividend: 5/15/2025
• Ex-Dividend for 5/29 Dividend: 5/15/2025
• Dividend Payable: 5/29/2025
• Today: 7/12/2025
• Next Earnings (Estimated): 7/31/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED - HMO
• Sub-Industry: Health Care Facilities
• Current Symbol: NYSE:SEM
• CIK: 1320414
• Web: www.selectmedicalcorp.com
• Phone: (717) 972-1100
• Fax: 717-972-1042
• Employees: 44,100
• Year Founded: 1996

Price Target and Rating

• Average Price Target for Select Medical: $26.00
• High Price Target: $42.00
• Low Price Target: $19.00
• Potential Upside/Downside: +76.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.80
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.34
• Trailing P/E Ratio: 10.99
• Forward P/E Ratio: 12.58
• P/E Growth: 0.78
• Net Income: $214.04 million
• Net Margins: 2.81%
• Pretax Margin: 2.95%
• Return on Equity: 11.04%
• Return on Assets: 3.25%

Debt

• Debt-to-Equity Ratio: 0.87
• Current Ratio: 1.16
• Quick Ratio: 1.16

Sales & Book Value

• Annual Sales: $5.19 billion
• Price / Sales: 0.36
• Cash Flow: $2.52 per share
• Price / Cash Flow: 5.84
• Book Value: $15.35 per share
• Price / Book: 0.96

Miscellaneous

• Outstanding Shares: 128,540,000
• Free Float: 113,628,000
• Market Cap: $1.89 billion
• Optionable: Optionable
• Beta: 1.32